Recent Progress on Hormonal Receptor Positive Breast Cancer

Breast cancer is a complex and heterogeneous disease, with hormonal receptor positive breast cancer being one of the most common subtypes. Recent advancements in understanding the molecular mechanisms and therapeutic strategies for hormonal receptor positive breast cancer have opened new avenues for research and clinical practice. Despite improvements in treatment outcomes, challenges such as resistance to endocrine therapy and disease recurrence persist, highlighting the need for continued research efforts to enhance patient care and outcomes.

The goal of this Collection is to provide a platform for researchers, clinicians, and experts to share their cutting-edge research, innovative approaches, and insightful perspectives on hormonal receptor positive breast cancer. Researchers are invited to submit work that addresses key areas such as novel therapeutic targets, biomarker discovery, mechanisms of resistance, precision medicine approaches, and clinical trial outcomes in hormonal receptor positive breast cancer. Manuscripts developed in laboratory animal models or in spontaneous tumors of dogs and cats, are also welcome. Through this Collection, we aim to advance the field, improve patient outcomes, and ultimately contribute to the global effort to combat breast cancer.

Keywords: hormonal receptor positive breast cancer, therapeutic targets, biomarkers, molecular mechanisms, precision medicine